COVISTA INC (CVSA) Stock Fundamental Analysis
NYSE:CVSA • US00737L1035
98 USD
-0.76 (-0.77%)
At close: Feb 27, 2026
98 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Taking everything into account, CVSA scores 7 out of 10 in our fundamental rating. CVSA was compared to 75 industry peers in the Diversified Consumer Services industry. CVSA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CVSA may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, CVSA could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
- CVSA had positive earnings in the past year.
- CVSA had a positive operating cash flow in the past year.
- CVSA had positive earnings in each of the past 5 years.
- Each year in the past 5 years CVSA had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of CVSA (9.69%) is better than 82.67% of its industry peers.
- Looking at the Return On Equity, with a value of 18.37%, CVSA belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 13.77%, CVSA belongs to the top of the industry, outperforming 89.33% of the companies in the same industry.
- CVSA had an Average Return On Invested Capital over the past 3 years of 9.63%. This is in line with the industry average of 11.18%.
- The 3 year average ROIC (9.63%) for CVSA is below the current ROIC(13.77%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.69% | ||
| ROE | 18.37% | ||
| ROIC | 13.77% |
ROA(3y)5.64%
ROA(5y)5.9%
ROE(3y)10.98%
ROE(5y)11.83%
ROIC(3y)9.63%
ROIC(5y)7.66%
1.3 Margins
- CVSA has a better Profit Margin (13.41%) than 85.33% of its industry peers.
- In the last couple of years the Profit Margin of CVSA has declined.
- CVSA has a better Operating Margin (19.55%) than 84.00% of its industry peers.
- CVSA's Operating Margin has improved in the last couple of years.
- CVSA's Gross Margin of 57.38% is fine compared to the rest of the industry. CVSA outperforms 74.67% of its industry peers.
- CVSA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.55% | ||
| PM (TTM) | 13.41% | ||
| GM | 57.38% |
OM growth 3Y19.65%
OM growth 5Y4.08%
PM growth 3Y-16.17%
PM growth 5YN/A
GM growth 3Y2.86%
GM growth 5Y1.26%
2. Health
2.1 Basic Checks
- CVSA has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, CVSA has less shares outstanding
- The debt/assets ratio for CVSA has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 4.33 indicates that CVSA is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.33, CVSA belongs to the best of the industry, outperforming 85.33% of the companies in the same industry.
- CVSA has a debt to FCF ratio of 1.37. This is a very positive value and a sign of high solvency as it would only need 1.37 years to pay back of all of its debts.
- CVSA has a Debt to FCF ratio of 1.37. This is amongst the best in the industry. CVSA outperforms 85.33% of its industry peers.
- A Debt/Equity ratio of 0.37 indicates that CVSA is not too dependend on debt financing.
- CVSA's Debt to Equity ratio of 0.37 is in line compared to the rest of the industry. CVSA outperforms 52.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 1.37 | ||
| Altman-Z | 4.33 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CVSA has a Current Ratio of 0.68. This is a bad value and indicates that CVSA is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.68, CVSA is not doing good in the industry: 70.67% of the companies in the same industry are doing better.
- A Quick Ratio of 0.68 indicates that CVSA may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.68, CVSA is doing worse than 70.67% of the companies in the same industry.
- The current and quick ratio evaluation for CVSA is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.68 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
- CVSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.98%, which is quite impressive.
- The Earnings Per Share has been growing by 23.77% on average over the past years. This is a very strong growth
- The Revenue has grown by 11.92% in the past year. This is quite good.
- Measured over the past years, CVSA shows a quite strong growth in Revenue. The Revenue has been growing by 11.19% on average per year.
EPS 1Y (TTM)29.98%
EPS 3Y23.46%
EPS 5Y23.77%
EPS Q2Q%34.25%
Revenue 1Y (TTM)11.92%
Revenue growth 3Y8.97%
Revenue growth 5Y11.19%
Sales Q2Q%12.43%
3.2 Future
- Based on estimates for the next years, CVSA will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.34% on average per year.
- Based on estimates for the next years, CVSA will show a small growth in Revenue. The Revenue will grow by 7.53% on average per year.
EPS Next Y20.63%
EPS Next 2Y17.2%
EPS Next 3Y17.34%
EPS Next 5YN/A
Revenue Next Year8.9%
Revenue Next 2Y7.77%
Revenue Next 3Y7.53%
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 12.63, CVSA is valued correctly.
- 78.67% of the companies in the same industry are more expensive than CVSA, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.07. CVSA is valued rather cheaply when compared to this.
- The Price/Forward Earnings ratio is 10.68, which indicates a very decent valuation of CVSA.
- CVSA's Price/Forward Earnings ratio is rather cheap when compared to the industry. CVSA is cheaper than 86.67% of the companies in the same industry.
- CVSA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.63 | ||
| Fwd PE | 10.68 |
4.2 Price Multiples
- 72.00% of the companies in the same industry are more expensive than CVSA, based on the Enterprise Value to EBITDA ratio.
- CVSA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CVSA is cheaper than 89.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.19 | ||
| EV/EBITDA | 9.07 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of CVSA may justify a higher PE ratio.
- A more expensive valuation may be justified as CVSA's earnings are expected to grow with 17.34% in the coming years.
PEG (NY)0.61
PEG (5Y)0.53
EPS Next 2Y17.2%
EPS Next 3Y17.34%
5. Dividend
5.1 Amount
- CVSA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
98
-0.76 (-0.77%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-28 2026-01-28/amc
Earnings (Next)05-06 2026-05-06
Inst Owners102.79%
Inst Owner ChangeN/A
Ins Owners1.45%
Ins Owner ChangeN/A
Market Cap3.38B
Revenue(TTM)1.89B
Net Income(TTM)253.25M
Analysts88
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.83%
Min EPS beat(2)8.76%
Max EPS beat(2)8.91%
EPS beat(4)4
Avg EPS beat(4)9.44%
Min EPS beat(4)6.2%
Max EPS beat(4)13.91%
EPS beat(8)8
Avg EPS beat(8)13.85%
EPS beat(12)12
Avg EPS beat(12)14.37%
EPS beat(16)16
Avg EPS beat(16)13.93%
Revenue beat(2)2
Avg Revenue beat(2)0.59%
Min Revenue beat(2)0.2%
Max Revenue beat(2)0.98%
Revenue beat(4)4
Avg Revenue beat(4)1.27%
Min Revenue beat(4)0.2%
Max Revenue beat(4)2.26%
Revenue beat(8)8
Avg Revenue beat(8)1.79%
Revenue beat(12)12
Avg Revenue beat(12)1.77%
Revenue beat(16)14
Avg Revenue beat(16)7.41%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.63 | ||
| Fwd PE | 10.68 | ||
| P/S | 1.79 | ||
| P/FCF | 9.19 | ||
| P/OCF | 7.9 | ||
| P/B | 2.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.07 |
EPS(TTM)7.76
EY7.92%
EPS(NY)9.17
Fwd EY9.36%
FCF(TTM)10.66
FCFY10.88%
OCF(TTM)12.4
OCFY12.65%
SpS54.73
BVpS39.95
TBVpS-9.92
PEG (NY)0.61
PEG (5Y)0.53
Graham Number83.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.69% | ||
| ROE | 18.37% | ||
| ROCE | 17% | ||
| ROIC | 13.77% | ||
| ROICexc | 14.13% | ||
| ROICexgc | 75.81% | ||
| OM | 19.55% | ||
| PM (TTM) | 13.41% | ||
| GM | 57.38% | ||
| FCFM | 19.48% |
ROA(3y)5.64%
ROA(5y)5.9%
ROE(3y)10.98%
ROE(5y)11.83%
ROIC(3y)9.63%
ROIC(5y)7.66%
ROICexc(3y)10.68%
ROICexc(5y)8.65%
ROICexgc(3y)69.89%
ROICexgc(5y)49.9%
ROCE(3y)11.9%
ROCE(5y)9.46%
ROICexgc growth 3Y43.58%
ROICexgc growth 5Y21.13%
ROICexc growth 3Y34.8%
ROICexc growth 5Y6.87%
OM growth 3Y19.65%
OM growth 5Y4.08%
PM growth 3Y-16.17%
PM growth 5YN/A
GM growth 3Y2.86%
GM growth 5Y1.26%
F-Score8
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 1.37 | ||
| Debt/EBITDA | 1.19 | ||
| Cap/Depr | 112.6% | ||
| Cap/Sales | 3.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.29% | ||
| Profit Quality | 145.32% | ||
| Current Ratio | 0.68 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 4.33 |
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)65.95%
Cap/Depr(5y)64.36%
Cap/Sales(3y)2.82%
Cap/Sales(5y)3.22%
Profit Quality(3y)159.84%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.98%
EPS 3Y23.46%
EPS 5Y23.77%
EPS Q2Q%34.25%
EPS Next Y20.63%
EPS Next 2Y17.2%
EPS Next 3Y17.34%
EPS Next 5YN/A
Revenue 1Y (TTM)11.92%
Revenue growth 3Y8.97%
Revenue growth 5Y11.19%
Sales Q2Q%12.43%
Revenue Next Year8.9%
Revenue Next 2Y7.77%
Revenue Next 3Y7.53%
Revenue Next 5YN/A
EBIT growth 1Y11.93%
EBIT growth 3Y30.39%
EBIT growth 5Y15.73%
EBIT Next Year38.69%
EBIT Next 3Y18.01%
EBIT Next 5YN/A
FCF growth 1Y87.3%
FCF growth 3YN/A
FCF growth 5Y35.23%
OCF growth 1Y68.41%
OCF growth 3Y217.06%
OCF growth 5Y25.69%
COVISTA INC / CVSA FAQ
What is the ChartMill fundamental rating of COVISTA INC (CVSA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to CVSA.
Can you provide the valuation status for COVISTA INC?
ChartMill assigns a valuation rating of 8 / 10 to COVISTA INC (CVSA). This can be considered as Undervalued.
What is the profitability of CVSA stock?
COVISTA INC (CVSA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for CVSA stock?
The Price/Earnings (PE) ratio for COVISTA INC (CVSA) is 12.63 and the Price/Book (PB) ratio is 2.45.
What is the financial health of COVISTA INC (CVSA) stock?
The financial health rating of COVISTA INC (CVSA) is 7 / 10.